Encontrado 1 documento, a visualizar página 1 de 1
Ordenado por
Data
ir para a página:
1
Efficacy and Safety of Fremanezumab in Patients with Migraine: Real-World Evide...
Lopo Vitorino, Marli; Pavão Martins, IsabelIntroduction: Migraine is the first cause of disability under 50 years of age. In the last decade there were significant advances in the comprehension of this disorder that led to the development of specific treatments, such as those targeting calcitonin gene-related peptide (CGRP) or its receptor including monoclonal antibodies. Here, we present real life results of a cohort of migraine patients treated with f...
Data: 2024
|
Origem: SINAPSE